Tricyclic compound and medical use thereof
    4.
    发明授权
    Tricyclic compound and medical use thereof 有权
    三环化合物及其医疗用途

    公开(公告)号:US08273761B2

    公开(公告)日:2012-09-25

    申请号:US12448094

    申请日:2007-12-07

    IPC分类号: C07D491/048 A61K31/4355

    CPC分类号: C07D491/04 C07D491/14

    摘要: The present invention provides a compound represented by the formula wherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group optionally having substituent(s), R2 is a hydrogen atom or a hydrocarbon group optionally having substituent(s), R3 is a hydrogen atom, a halogen atom, a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or mercapto optionally having a substituent, Xa to Xe are each a carbon atom or a nitrogen atom, m is 0 to 2, and ring A to ring C are each a ring optionally having substituent(s), or a salt thereof, which is useful as an agent for the prophylaxis or treatment of a disease relating to an action of melatonin, and the like.

    摘要翻译: 本发明提供由下式表示的化合物,其中R 1是任选具有取代基的烃基,任选具有取代基的氨基,任选具有取代基的羟基或任选具有取代基的杂环基,R2是 氢原子或任选具有取代基的烃基,R 3是氢原子,卤素原子,任选具有取代基的烃基,任选具有取代基的氨基,任选具有取代基的羟基或任选具有取代基的巯基, 取代基,Xa〜Xe各自为碳原子或氮原子,m为0〜2,环A〜环C各自为任选具有取代基的环,或其盐,可用作试剂 用于预防或治疗与褪黑素的作用相关的疾病等。

    TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF
    6.
    发明申请
    TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF 有权
    三氯化合物及其药物用途

    公开(公告)号:US20100010038A1

    公开(公告)日:2010-01-14

    申请号:US12448366

    申请日:2007-12-27

    摘要: The present invention provides a compound represented by the formula wherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group optionally having substituent(s), R2 is a hydrogen atom or a hydrocarbon group optionally having substituent(s), R3 is a hydrogen atom, a halogen atom, a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or mercapto optionally having a substituent, Xa, Xb, Xc and Xd are each a carbon atom or a nitrogen atom, provided that any one or two of Xa, Xb, Xc and Xd is/are nitrogen atom(s), m is 0 to 2, and rings A to C are each a ring optionally having substituent(s), or a salt thereof, which is useful as an agent for the prophylaxis or treatment of a disease relating to an action of melatonin, and the like.

    摘要翻译: 本发明提供由下式表示的化合物,其中R 1是任选具有取代基的烃基,任选具有取代基的氨基,任选具有取代基的羟基或任选具有取代基的杂环基,R2是 氢原子或任选具有取代基的烃基,R 3是氢原子,卤素原子,任选具有取代基的烃基,任选具有取代基的氨基,任选具有取代基的羟基或任选具有取代基的巯基, 取代基Xa,Xb,Xc和Xd各自为碳原子或氮原子,条件是Xa,Xb,Xc和Xd中的任何一个或两个为氮原子,m为0至2,并且 环A至C各自为任选具有取代基的环或其盐,其可用作预防或治疗与褪黑素的作用有关的疾病等。

    Tricyclic compound and pharmaceutical use thereof
    8.
    发明授权
    Tricyclic compound and pharmaceutical use thereof 有权
    三环化合物及其药物用途

    公开(公告)号:US08247429B2

    公开(公告)日:2012-08-21

    申请号:US12448366

    申请日:2007-12-27

    摘要: The present invention provides a compound represented by the formula wherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group optionally having substituent(s), R2 is a hydrogen atom or a hydrocarbon group optionally having substituent(s), R3 is a hydrogen atom, a halogen atom, a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or mercapto optionally having a substituent, Xa, Xb, Xc and Xd are each a carbon atom or a nitrogen atom, provided that any one or two of Xa, Xb, Xc and Xd is/are nitrogen atom(s), m is 0 to 2, and rings A to C are each a ring optionally having substituent(s), or a salt thereof, which is useful as an agent for the prophylaxis or treatment of a disease relating to an action of melatonin, and the like.

    摘要翻译: 本发明提供由下式表示的化合物,其中R 1是任选具有取代基的烃基,任选具有取代基的氨基,任选具有取代基的羟基或任选具有取代基的杂环基,R2是 氢原子或任选具有取代基的烃基,R 3是氢原子,卤素原子,任选具有取代基的烃基,任选具有取代基的氨基,任选具有取代基的羟基或任选具有取代基的巯基, 取代基Xa,Xb,Xc和Xd各自为碳原子或氮原子,条件是Xa,Xb,Xc和Xd中的任何一个或两个为氮原子,m为0至2,并且 环A至C各自为任选具有取代基的环或其盐,其可用作预防或治疗与褪黑素的作用有关的疾病等。

    TRICYCLIC COMPOUND AND MEDICAL USE THEREOF
    10.
    发明申请
    TRICYCLIC COMPOUND AND MEDICAL USE THEREOF 有权
    三环化合物及其医疗用途

    公开(公告)号:US20100029707A1

    公开(公告)日:2010-02-04

    申请号:US12448094

    申请日:2007-12-07

    CPC分类号: C07D491/04 C07D491/14

    摘要: The present invention provides a compound represented by the formula wherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group optionally having substituent(s), R2 is a hydrogen atom or a hydrocarbon group optionally having substituent(s), R3 is a hydrogen atom, a halogen atom, a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or mercapto optionally having a substituent, Xa to Xe are each a carbon atom or a nitrogen atom, m is 0 to 2, and ring A to ring C are each a ring optionally having substituent(s), or a salt thereof, which is useful as an agent for the prophylaxis or treatment of a disease relating to an action of melatonin, and the like.

    摘要翻译: 本发明提供由下式表示的化合物,其中R 1是任选具有取代基的烃基,任选具有取代基的氨基,任选具有取代基的羟基或任选具有取代基的杂环基,R2是 氢原子或任选具有取代基的烃基,R 3是氢原子,卤素原子,任选具有取代基的烃基,任选具有取代基的氨基,任选具有取代基的羟基或任选具有取代基的巯基, 取代基,Xa〜Xe各自为碳原子或氮原子,m为0〜2,环A〜环C各自为任选具有取代基的环,或其盐,可用作试剂 用于预防或治疗与褪黑素的作用相关的疾病等。